Overview and Scope
Single-cell analysis is the study of transcriptomics, genomics, proteomics, cell interactions, and metabolomics at the level of a single cell. It helps in standardizing and automating the workflows with information useful in the treatment of various diseases such as cancer. The single-cell analysis is engaged in conducting research and experimental development in single-cell analysis.
Sizing and Forecast
The single-cell analysis market size has grown rapidly in recent years. It will grow from $3.14 billion in 2023 to $3.53 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to rising research in genomics, increased funding, biopharmaceutical r&d.
The single-cell analysis market size is expected to see rapid growth in the next few years. It will grow to $6.02 billion in 2028 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to wider application scope, rising adoption in clinical diagnostics, advancements in data analysis. Major trends in the forecast period include collaborations and partnerships, multi-omics integration, single-cell spatial analysis, automation and high-throughput technologies, ai and machine learning integration, expanding applications in neurology.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-global-market-report
Segmentation & Regional Insights
The single-cell analysis market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Workflow: Single-cell Isolation And Library Preparation, Downstream Analysis, Data Analysis
3) By Technique: Flow Cytometry, Next Generation Sequencing, Polymerase Chain Reaction (PCR), Microscopy, Mass Spectrometry, Other Techniques
4) By Application: Cancer, Immunology, Neurology, Stem cell, Non-invasive prenatal diagnosis, In-vitro fertilization, Other Applications
5) By End User: Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospital and Diagnostic Laboratories
North America was the largest region in the single-cell analysis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6430&type=smp
Major Driver Impacting Market Growth
The growing focus on personalized medicine across the globe is contributing to the growth of the single-cell analysis market. Personalized medicine is a medical practice that uses a genetic profile of a particular individual to make decisions for the treatment of a disease and also for the prevention and diagnosis of the disease for that specific individual. The single-cell analysis could help in the treatment of various diseases by giving deep insights into the needs of individual patients, the nature of the disease, and the personalized treatment for it. Thus, more patients are opting for personalized medicines for themselves. For example, according to the survey conducted in July 2021, by Dosis, a dosing platform provider, of 1,000 people, 85% of patients think that personalized medicine will improve care for them and 80% of patients think that personalized medicine should be available for all. Hence, the increasing focus on personalized medicine is supporting the growth of the market.
Key Industry Players
Major companies operating in the single-cell analysis market report are Becton Dickinson and Company, Merck KGAA, QIAGEN N. V., Thermo Fisher Scientific Inc., Illumina Inc., Standard BioTools Inc., 10X Genomics Inc., Bio-Rad Laboratories Inc., Novogene Corporation Limited, Agilent Technologies Inc., Sartorius AG, Luminex Corporation, Fluxion Biosciences Inc., Oxford Nanopore Technologies Ltd., 1CellBio Inc., 3D Biomatrix Inc., ACEA Biosciences Inc., Akoya Biosciences Inc., Berkeley Lights Inc., Bio-Techne Corporation, Celsee Inc., Cellular Research Inc., Cytena GmbH, Dolomite Bio Limited, Drop-seq Technologies Inc., Epic Sciences Inc., Ginkgo Bioworks Inc., IsoPlexis Corporation, Menarini Silicon Biosystems S. p. A., Mission Bio Inc., NanoCellect Biomedical Inc., NemaMetrix Inc., OnRamp Bioinformatics Inc., Partek Incorporated, RareCyte Inc., Scienion AG, SeqWell Inc., Sphere Fluidics Limited, Takara Bio USA Holdings Inc.
The single-cell analysis market report table of contents includes:
1. Executive Summary
2. Single-cell Analysis Market Characteristics
3. Single-cell Analysis Market Trends And Strategies
4. Single-cell Analysis Market – Macro Economic Scenario
5. Global Single-cell Analysis Market Size and Growth
.
.
.
31. Global Single-cell Analysis Market Competitive Benchmarking
32. Global Single-cell Analysis Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Single-cell Analysis Market
34. Single-cell Analysis Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
